The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Lags Revenue Estimates
- The Oncology Institute reported a quarterly loss of $0.22 per share, missing estimates. - The company's revenue for the quarter was $94.67 million, slightly below expectations. - TOI shares have decreased by 57.4% this year, underperforming the market significantly. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings
View signal analysis